143 related articles for article (PubMed ID: 21873526)
1. Glycogen synthase kinase-3 facilitates con a-induced IFN-γ-- mediated immune hepatic injury.
Tsai CC; Huang WC; Chen CL; Hsieh CY; Lin YS; Chen SH; Yang KC; Lin CF
J Immunol; 2011 Oct; 187(7):3867-77. PubMed ID: 21873526
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting glycogen synthase kinase-3 decreases 12-O-tetradecanoylphorbol-13-acetate-induced interferon-γ-mediated skin inflammation.
Hsieh CY; Chen CL; Tsai CC; Huang WC; Tseng PC; Lin YS; Chen SH; Wong TW; Choi PC; Lin CF
J Pharmacol Exp Ther; 2012 Oct; 343(1):125-33. PubMed ID: 22773863
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1.
Jaruga B; Hong F; Kim WH; Gao B
Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1044-52. PubMed ID: 15246962
[TBL] [Abstract][Full Text] [Related]
4. A critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide.
Cao Z; Dhupar R; Cai C; Li P; Billiar TR; Geller DA
J Immunol; 2010 Aug; 185(4):2536-43. PubMed ID: 20624945
[TBL] [Abstract][Full Text] [Related]
5. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes.
Tagawa Y; Sekikawa K; Iwakura Y
J Immunol; 1997 Aug; 159(3):1418-28. PubMed ID: 9233639
[TBL] [Abstract][Full Text] [Related]
6. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice.
Kato J; Okamoto T; Motoyama H; Uchiyama R; Kirchhofer D; Van Rooijen N; Enomoto H; Nishiguchi S; Kawada N; Fujimoto J; Tsutsui H
Hepatology; 2013 Jan; 57(1):362-72. PubMed ID: 22936459
[TBL] [Abstract][Full Text] [Related]
8. CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis.
Erhardt A; Wegscheid C; Claass B; Carambia A; Herkel J; Mittrücker HW; Panzer U; Tiegs G
J Immunol; 2011 May; 186(9):5284-93. PubMed ID: 21441449
[TBL] [Abstract][Full Text] [Related]
9. A key pathogenic role for the STAT1/T-bet signaling pathway in T-cell-mediated liver inflammation.
Siebler J; Wirtz S; Klein S; Protschka M; Blessing M; Galle PR; Neurath MF
Hepatology; 2003 Dec; 38(6):1573-80. PubMed ID: 14647068
[TBL] [Abstract][Full Text] [Related]
10. IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet.
Siebler J; Wirtz S; Weigmann B; Atreya I; Schmitt E; Kreft A; Galle PR; Neurath MF
Gastroenterology; 2007 Jan; 132(1):358-71. PubMed ID: 17241885
[TBL] [Abstract][Full Text] [Related]
11. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury.
Wang J; Sun R; Wei H; Dong Z; Tian Z
Int Immunopharmacol; 2006 May; 6(5):800-7. PubMed ID: 16546711
[TBL] [Abstract][Full Text] [Related]
12. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism.
Wang J; Sun R; Wei H; Dong Z; Gao B; Tian Z
J Hepatol; 2006 Mar; 44(3):446-54. PubMed ID: 16310275
[TBL] [Abstract][Full Text] [Related]
13. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice.
Mizuhara H; Kuno M; Seki N; Yu WG; Yamaoka M; Yamashita M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
Hepatology; 1998 Feb; 27(2):513-9. PubMed ID: 9462651
[TBL] [Abstract][Full Text] [Related]
14. The differential effects of low dose and high dose concanavalin A on cytokine profile and their importance in liver injury.
Xu X; Wei H; Dong Z; Chen Y; Tian Z
Inflamm Res; 2006 Apr; 55(4):144-52. PubMed ID: 16807695
[TBL] [Abstract][Full Text] [Related]
15. Chronic inflammatory IFN-γ signaling suppresses hepatocarcinogenesis in mice by sensitizing hepatocytes for apoptosis.
Lüth S; Schrader J; Zander S; Carambia A; Buchkremer J; Huber S; Reifenberg K; Yamamura K; Schirmacher P; Lohse AW; Herkel J
Cancer Res; 2011 Jun; 71(11):3763-71. PubMed ID: 21512142
[TBL] [Abstract][Full Text] [Related]
16. Selective elimination of hepatic natural killer T cells with concanavalin A improves liver regeneration in mice.
Huang W; Dong Z; Wei H; Ding C; Sun R; Tian Z
Liver Int; 2006 Apr; 26(3):339-45. PubMed ID: 16584397
[TBL] [Abstract][Full Text] [Related]
17. Induction of thymocyte apoptosis by systemic administration of concanavalin A in mice: role of TNF-alpha, IFN-gamma and glucocorticoids.
Fayad R; Sennello JA; Kim SH; Pini M; Dinarello CA; Fantuzzi G
Eur J Immunol; 2005 Aug; 35(8):2304-12. PubMed ID: 16047339
[TBL] [Abstract][Full Text] [Related]
18. Lack of macrophage migration inhibitory factor protects mice against concanavalin A-induced liver injury.
Nakajima H; Takagi H; Horiguchi N; Toyoda M; Kanda D; Otsuka T; Emoto Y; Emoto M; Mori M
Liver Int; 2006 Apr; 26(3):346-51. PubMed ID: 16584398
[TBL] [Abstract][Full Text] [Related]
19. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.
Toyabe S; Seki S; Iiai T; Takeda K; Shirai K; Watanabe H; Hiraide H; Uchiyama M; Abo T
J Immunol; 1997 Aug; 159(3):1537-42. PubMed ID: 9233653
[TBL] [Abstract][Full Text] [Related]
20. Concanavalin A hepatotoxicity in mice: tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation.
Künstle G; Hentze H; Germann PG; Tiegs G; Meergans T; Wendel A
Hepatology; 1999 Nov; 30(5):1241-51. PubMed ID: 10534346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
